...
首页> 外文期刊>Brain: A journal of neurology >Next-generation sequencing reveals DGUOK mutations in adult patients with mitochondrial DNA multiple deletions
【24h】

Next-generation sequencing reveals DGUOK mutations in adult patients with mitochondrial DNA multiple deletions

机译:下一代测序揭示具有线粒体DNA多重缺失的成年患者中的DGUOK突变

获取原文
获取原文并翻译 | 示例

摘要

The molecular diagnosis of mitochondrial disorders still remains elusive in a large proportion of patients, but advances in next generation sequencing are significantly improving our chances to detect mutations even in sporadic patients. Syndromes associated with mitochondrial DNA multiple deletions are caused by different molecular defects resulting in a wide spectrum of predominantly adult-onset clinical presentations, ranging from progressive external ophthalmoplegia to multi-systemic disorders of variable severity. The mutations underlying these conditions remain undisclosed in half of the affected subjects. We applied next-generation sequencing of known mitochondrial targets (MitoExome) to probands presenting with adult-onset mitochondrial myopathy and harbouring mitochondrial DNA multiple deletions in skeletal muscle. We identified autosomal recessive mutations in the DGUOK gene (encoding mitochondrial deoxyguanosine kinase), which has previously been associated with an infantile hepatocerebral form of mitochondrial DNA depletion. Mutations in DGUOK occurred in five independent subjects, representing 5.6% of our cohort of patients with mitochondrial DNA multiple deletions, and impaired both muscle DGUOK activity and protein stability. Clinical presentations were variable, including mitochondrial myopathy with or without progressive external ophthalmoplegia, recurrent rhabdomyolysis in a young female who had received a liver transplant at 9 months of age and adult-onset lower motor neuron syndrome with mild cognitive impairment. These findings reinforce the concept that mutations in genes involved in deoxyribonucleotide metabolism can cause diverse clinical phenotypes and suggest that DGUOK should be screened in patients harbouring mitochondrial DNA deletions in skeletal muscle.
机译:线粒体疾病的分子诊断在大多数患者中仍然难以捉摸,但是下一代测序技术的进步极大地提高了我们检测突变的机会,即使在散发性患者中也是如此。与线粒体DNA多重缺失相关的综合征是由不同的分子缺陷引起的,导致了广泛的成人发病临床表现,从进行性眼外肌麻痹到严重程度不一的多系统性疾病。这些条件下的突变在一半的受影响受试者中仍未公开。我们将已知的线粒体靶标(MitoExome)的下一代测序应用到了患有成人线粒体肌病且骨骼肌中线粒体DNA多重缺失的先证者。我们在DGUOK基因(编码线粒体脱氧鸟苷激酶)中鉴定了常染色体隐性突变,该基因先前与线粒体DNA消耗的小儿肝脑形式有关。 DGUOK突变发生在五个独立的受试者中,占我们线粒体DNA多重缺失患者队列的5.6%,并且损害了肌肉DGUOK活性和蛋白质稳定性。临床表现各不相同,包括线粒体肌病伴或不伴进行性外部眼肌麻痹,在9个月大时接受肝移植的年轻女性的反复横纹肌溶解和成人发作的下运动神经元综合征伴轻度认知障碍。这些发现加强了这样的概念,即涉及脱氧核糖核苷酸代谢的基因突变会引起多种临床表型,并建议在骨骼肌线粒体DNA缺失的患者中筛查DGUOK。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号